Showing results (221-230 of 261) with videos related to
Sort By:
Pageof 27
Hepatology (Baltimore, Md.)|April 27, 2011
Transforming growth factor-β adaptor, β2-spectrin, modulates cyclin dependent kinase 4 to reduce development of hepatocellular cancerHye Jung Baek, Michael J Pishvaian, Yi Tang, et al.Cell Reports. Medicine|July 8, 2025
Unlocking the therapeutic potential of rigosertib as a selective therapy for ovarian cancerShalini Nath, Sally Claridge, Genesis Lara Granados, et al.Nature Communications|August 4, 2021
Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant diseaseKatsutoshi Sato, Amol A Padgaonkar, Stacey J Baker, et al.Journal of Medicinal Chemistry|January 15, 2014
Discovery of 8-cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile (7x) as a potent inhibitor of cyclin-dependent kinase 4 (CDK4) and AMPK-related kinase 5 (ARK5)M V Ramana Reddy, Balireddy Akula, Stephen C Cosenza, et al.Bioorganic & Medicinal Chemistry|January 15, 2016
Discovery of 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one (7ao) as a potent selective inhibitor of Polo like kinase 2 (PLK2)M V Ramana Reddy, Balireddy Akula, Shashidhar Jatiani, et al.Cell|April 23, 2016
A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block SignalingSai Krishna Athuluri-Divakar, Rodrigo Vasquez-Del Carpio, Kaushik Dutta, et al.Transplantation|February 3, 1998
A tacrolimus-related immunosuppressant with reduced toxicityF J Dumont, S Koprak, M J Staruch, et al.Transplantation|February 3, 1998
A tacrolimus-related immunosuppressant with biochemical properties distinct from those of tacrolimusL B Peterson, J G Cryan, R Rosa, et al.Pharmacological Reviews|March 27, 2025
Cell cycle dysregulation in cancerAntonino Glaviano, Samarendra K Singh, E Hui Clarissa Lee, et al.Cell Stem Cell|February 21, 2017
Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable LeukemiaAndriana G Kotini, Chan-Jung Chang, Arthur Chow, et al.Pageof 27